Deciphera Pharmaceuticals, Inc. (DCPH) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.37B |
| Enterprise Value | 1.31B |
| P/E Ratio | -11.17 |
| PEG Ratio | -3.93 |
| Price/Sales Ratio | 13.55 |
| Price/Book Ratio | 6.2 |
| Enterprise/Revenue | 13.19 |
| Enterprise/EBITDA | -10.32 |
| Fiscal Year | December 31, 2023 |
| Most Recent Quarter | March 31, 2024 |
| Profit Margin | -1.19 |
| Operating Margin | -1.29 |
| Return On Assets | -0.41 |
| Return On Equity | -0.56 |
| Revenue | 163.36M |
| Revenue/Share | 1.92 |
| Gross Profit | 159.62M |
| EBITDA | -208.86M |
| Net Income | -194.94M |
| Diluted EPS | -2.29 |
| Total Cash | 272.53M |
| Total Cash/Share | 3.6 |
| Total Debt | 25.02M |
| Total Debt/Equity | 0.07 |
| Current Ratio | 3.8 |
| Book Value Per Share | 4.13 |
| 52-Week Change | 86.92 |
| 52-Week High | 25.61 |
| 52-Week Low | 9.9 |
| Moving Average 50 Days | 21.07 |
| Moving Average 200 Days | 15.75 |
| Average Volume | 1.86M |
| Shares Outstanding | 86.48M |
| % Held by Institutions | 0.06 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |